TRUPRIMATE

USPTO USPTO 2000 CANCELLED - SECTION 8

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The US trademark TRUPRIMATE was filed as Word mark on 08/16/2000 at the U.S. Patent and Trademark Office.
It was registered as a trademark on 04/09/2002. The current status of the mark is "CANCELLED - SECTION 8".

Trademark Details Last update: May 16, 2018

Trademark form Word mark
File reference 76113589
Register number 2558208
Application date August 16, 2000
Publication date January 15, 2002
Entry date April 9, 2002

Trademark owner

7 Clarke Drive
08512 Cranbury
US

Trademark representatives

goods and services

1 Describing and providing scientific and research preparations, namely, simian genetic material models for testing pharmaceuticals and treatments for human respiratory ailments, including symptoms such as bronchoconstriction, difficult breathing, impeded and obstructed lung airways, allergy(ies) and/or inflammation, which in many cases are adenosine receptor associated symptoms, particularly marmosets for use in testing preventative and therapeutic treatments for respiratory, airway and pulmonary diseases, such as asthma, pulmonary vasoconstriction, inflammation, allergies, asthma, impeded respiration, Acute Respiratory Distress Syndrome (ARDS), renal damage and failure associated with ischemia as well as the administration of certain drugs, side effects associated with adenosine administration such as when treating Supra Ventricular tachycardia (SVT) and in adenosine stress tests, infantile Respiratory Distress Syndrome (infantile RDS), pain, cystic fibrosis, allergic rhinitis, allergic bronchitis, pulmonary hypertension, pulmonary vasoconstriction, emphysema, chronic obstructive pulmonary disease (COPD), as well as cancers such as leukemias, lymphomas, carcinomas, and the like, e.g. colon cancer, breast cancer, lung cancer, pancreatic cancer, hepatocellular carcinoma, kidney cancer, melanoma, hepatic metastases, etc., as well as other metastatic cancers, e.g. cancers which metastasized to the lung(s), breast and prostate

ID: 1376113589